When 21-year PwC veteran Mark McCaffrey decided that it was time to open his post-PwC career, he briefed the firm’s U. S leadership about his plans, diligently outline...
As go-to-market times shorten and the probabilities of a drug’s success grows, CFO Jamey Mock is championing the advantages of “de-risking” drug development.
From his earliest days roaming corporate corridors, Aaron Alt has benefited from what evades most finance career-builders for decades: boardroom access.